Showing results (451-460 of 767) with videos related to
Sort By:
Pageof 77
Research in Veterinary Science|March 11, 2026
Parvoviral active surveillance in a veterinary teaching hospital in Northern ItalyVeronica Facile, Laura Gallina, Martina Magliocca, et al.Journal of Wildlife Diseases|February 22, 2019
Genetic Characterization of Canine Adenovirus Type 1 Detected by Real-Time Polymerase Chain Reaction in an Oral Sample of an Italian Wolf (Canis Lupus)Andrea Balboni, Carmela Musto, Elisa Kaehler, et al.Veterinary Research Communications|May 5, 2022
Natural cases of polyarthritis associated with feline calicivirus infection in catsAndrea Balboni, Ranieri Verin, Isotta Buldrini, et al.Neuroreport|August 3, 2000
Characterization of N,N(Me)2-Dmt-Tic-OH, a delta selective opioid dipeptide antagonistK Monory, S D Bryant, I Kertész, et al.Cancer Genetics and Cytogenetics|September 1, 1996
Interleukin-3 plus interleukin-6 may improve chromosomal analysis of multiple myeloma: cytologic and cytogenetic evidence in thirty-four patientsA Cuneo, R Balsamo, M G Roberti, et al.Journal of Medicinal Chemistry|September 1, 2006
New opioid designed multiple ligand from Dmt-Tic and morphinan pharmacophoresJohn L Neumeyer, Xuemei Peng, Brian I Knapp, et al.Bioorganic Chemistry|November 4, 2019
Synthesis and evaluation of antioxidant and antiproliferative activity of 2-arylbenzimidazolesAnna Baldisserotto, Monica Demurtas, Ilaria Lampronti, et al.Practical Radiation Oncology|April 11, 2015
Postoperative radiation therapy for osseous metastasis: Outcomes and predictors of local failureZachary D Epstein-Peterson, Adam Sullivan, Monica Krishnan, et al.Bioorganic & Medicinal Chemistry|September 14, 2007
A new opioid designed multiple ligand derived from the micro opioid agonist endomorphin-2 and the delta opioid antagonist pharmacophore Dmt-TicSevero Salvadori, Claudio Trapella, Stella Fiorini, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2008
Racial and ethnic differences in advance care planning among patients with cancer: impact of terminal illness acknowledgment, religiousness, and treatment preferencesAlexander K Smith, Ellen P McCarthy, Elizabeth Paulk, et al.Pageof 77